Better Acceptance of a Single Injection Apidra (Insulin Glulisine) Added to Once Daily Lantus (Insulin Glargine) Versus Twice Daily Premixed Insulin in a Real Life Use Setting.
Phase of Trial: Phase IV
Latest Information Update: 28 May 2013
At a glance
- Drugs Insulin glulisine (Primary) ; Insulin aspart/insulin protamine aspart; Insulin glargine
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms BASAAL PLUS
- 01 Jun 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Feb 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 06 Apr 2011 Planned End Date changed from 1 Jul 2011 to 1 Jun 2012, as reported by ClinicalTrials.gov.